Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma(†)

OBJECTIVE: Eribulin, a microtubule dynamics inhibitor, is approved for the treatment of patients with breast cancer and soft tissue sarcoma. We investigated the efficacy and safety of eribulin in Japanese patients with soft tissue sarcoma. METHODS: This open-label, multicenter, nonrandomized, Phase...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Jpn J Clin Oncol
Main Authors: Kawai, Akira, Araki, Nobuhito, Naito, Yoichi, Ozaki, Toshifumi, Sugiura, Hideshi, Yazawa, Yasuo, Morioka, Hideo, Matsumine, Akihiko, Saito, Kenichi, Asami, Shun, Isu, Kazuo
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943671/
https://ncbi.nlm.nih.gov/pubmed/28173193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyw175
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados